BHVN
Biohaven Pharmaceutical Holding Co Ltd
NYSE: BHVN · HEALTHCARE · BIOTECHNOLOGY
$9.59
+4.24% today
Updated 2026-04-30
Market cap
$1.38B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.86
Dividend yield
—
52W range
$7 – $24
Volume
2.2M
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $146.89M | $290.01M | $344.26M | $111.50M | $142.06M | $661.78M | $513.21M | $615.11M |
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Current assets | $136.66M | $272.34M | $328.28M | $89.76M | $94.82M | $586.97M | $442.45M | $538.47M |
| Total liabilities | $14.92M | $139.09M | $351.69M | $34.72M | $47.37M | $123.01M | $85.24M | $191.67M |
| Current liabilities | $9.43M | $19.53M | $66.17M | $29.88M | $41.94M | $90.02M | $55.42M | $154.23M |
| Long-term debt | — | — | — | — | $626.72M | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — | — |
| Retained earnings | $-202.65M | $-443.57M | $-972.37M | $-1.74B | $-2.59B | $-91.12M | $-499.29M | $-1.35B |
| Accounts receivable | — | — | — | $120.11M | $9.91M | $46.14M | $13.25M | $2.60M |
| Inventory | — | — | — | $39.56M | $6.73M | $56.16M | $-396000.00 | — |
| Goodwill | — | — | — | $0.00 | $1.39M | $1.39M | $1.39M | $1.39M |